Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Teleflex Incorporated

NYSE

Market Cap.

9.72B

Avg. Volume

371.89K

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Teleflex Incorporated!

Still processing it, give me a bit more time...

Teleflex Incorporated News

Teleflex Incorporated Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Instruments & Supplies
teleflex.com

About Teleflex Incorporated

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Teleflex Incorporated Earnings & Revenue

Teleflex Incorporated Financials

Table Compare

Compare TFX metrics with:

   

Earnings & Growth

TFX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

TFX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

TFX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

TFX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Teleflex Incorporated Income

Teleflex Incorporated Balance Sheet

Teleflex Incorporated Cash Flow

Teleflex Incorporated Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Teleflex Incorporated Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.3600

Payment DateDividendFrequency
2024-06-140.34Quarterly
2024-03-150.34Quarterly
2023-12-150.34Quarterly
2023-09-150.34Quarterly
2023-06-150.34Quarterly

Historical Market Cap

Shares Outstanding

Teleflex Incorporated Executives

NameRole
Mr. Liam J. KellyChairman, President & Chief Executive Officer
Mr. Thomas E. Powell BS, MBAExecutive Vice President & Chief Financial Officer
Mr. Jay WhiteCorporate Vice President & President of Global Commercial
Mr. Daniel V. LogueCorporate Vice President, General Counsel & Secretary
Mr. Cameron P. HicksCorporate Vice President of Human Resources & Communications
NameRoleGenderDate of BirthPay
Mr. Liam J. KellyChairman, President & Chief Executive OfficerMale19672.63M
Mr. Thomas E. Powell BS, MBAExecutive Vice President & Chief Financial OfficerMale19621.29M
Mr. Jay WhiteCorporate Vice President & President of Global CommercialMale19741.09M
Mr. Daniel V. LogueCorporate Vice President, General Counsel & SecretaryMale1974720.27K
Mr. Cameron P. HicksCorporate Vice President of Human Resources & CommunicationsMale1965564.68K

Teleflex Incorporated Insider Trades

Date7 May
NameHAGGERTY GRETCHEN R
RoleDirector
TransactionAcquired
TypeA-Award
Shares649
Date7 May
NameHAGGERTY GRETCHEN R
RoleDirector
TransactionAcquired
TypeA-Award
Shares1349
Date7 May
NameKrakauer Andrew A
RoleDirector
TransactionAcquired
TypeA-Award
Shares649
Date7 May
NameKrakauer Andrew A
RoleDirector
TransactionAcquired
TypeA-Award
Shares1349
Date7 May
NameRANDLE STUART A
RoleDirector
TransactionAcquired
TypeA-Award
Shares649
DateNameRoleTransactionTypeShares
7 MayHAGGERTY GRETCHEN RDirectorAcquiredA-Award649
7 MayHAGGERTY GRETCHEN RDirectorAcquiredA-Award1349
7 MayKrakauer Andrew ADirectorAcquiredA-Award649
7 MayKrakauer Andrew ADirectorAcquiredA-Award1349
7 MayRANDLE STUART ADirectorAcquiredA-Award649

Discover More

Streamlined Academy

Teleflex Incorporated

NYSE

Market Cap.

9.72B

Avg. Volume

371.89K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Teleflex Incorporated News

Teleflex Incorporated Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Teleflex Incorporated Earnings & Revenue

Teleflex Incorporated Income

Teleflex Incorporated Balance Sheet

Teleflex Incorporated Cash Flow

Teleflex Incorporated Financials Over Time

Teleflex Incorporated Executives

NameRole
Mr. Liam J. KellyChairman, President & Chief Executive Officer
Mr. Thomas E. Powell BS, MBAExecutive Vice President & Chief Financial Officer
Mr. Jay WhiteCorporate Vice President & President of Global Commercial
Mr. Daniel V. LogueCorporate Vice President, General Counsel & Secretary
Mr. Cameron P. HicksCorporate Vice President of Human Resources & Communications
NameRoleGenderDate of BirthPay
Mr. Liam J. KellyChairman, President & Chief Executive OfficerMale19672.63M
Mr. Thomas E. Powell BS, MBAExecutive Vice President & Chief Financial OfficerMale19621.29M
Mr. Jay WhiteCorporate Vice President & President of Global CommercialMale19741.09M
Mr. Daniel V. LogueCorporate Vice President, General Counsel & SecretaryMale1974720.27K
Mr. Cameron P. HicksCorporate Vice President of Human Resources & CommunicationsMale1965564.68K

Teleflex Incorporated Insider Trades

Date7 May
NameHAGGERTY GRETCHEN R
RoleDirector
TransactionAcquired
TypeA-Award
Shares649
Date7 May
NameHAGGERTY GRETCHEN R
RoleDirector
TransactionAcquired
TypeA-Award
Shares1349
Date7 May
NameKrakauer Andrew A
RoleDirector
TransactionAcquired
TypeA-Award
Shares649
Date7 May
NameKrakauer Andrew A
RoleDirector
TransactionAcquired
TypeA-Award
Shares1349
Date7 May
NameRANDLE STUART A
RoleDirector
TransactionAcquired
TypeA-Award
Shares649
DateNameRoleTransactionTypeShares
7 MayHAGGERTY GRETCHEN RDirectorAcquiredA-Award649
7 MayHAGGERTY GRETCHEN RDirectorAcquiredA-Award1349
7 MayKrakauer Andrew ADirectorAcquiredA-Award649
7 MayKrakauer Andrew ADirectorAcquiredA-Award1349
7 MayRANDLE STUART ADirectorAcquiredA-Award649

Streamlined Academy

Website screenshot
HealthcareMedical - Instruments & Supplies
teleflex.com

About Teleflex Incorporated

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Teleflex Incorporated!

Still processing it, give me a bit more time...

Teleflex Incorporated Financials

Table Compare

Compare TFX metrics with:

   

Earnings & Growth

TFX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

TFX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

TFX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

TFX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Teleflex Incorporated Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.3600

Payment DateDividendFrequency
2024-06-140.34Quarterly
2024-03-150.34Quarterly
2023-12-150.34Quarterly
2023-09-150.34Quarterly
2023-06-150.34Quarterly

Teleflex Incorporated Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More